Myocardial infarction is a leading cause of death globally. Stem cell therapy is considered a potential treatment. Here, the authors propose an antioxidant polyurethane-based cardiac patch with ...
Myocardial infarction is a leading cause of death globally. Stem cell therapy is considered a potential treatment. Here, the authors propose an antioxidant polyurethane-based cardiac patch with ...
Cardiovascular diseases remain the leading cause of mortality globally, encompassing a range of disorders that affect the heart and blood vessels, including but not limited to ischemic heart disease, ...
The treatment is now just a step away from being the first ever allogeneic stem cell therapy approved ... in a Phase 1/2 trial in acute myocardial infarction.
Takeda is to acquire TiGenix, the stem cell specialist biotech with which it has developed a gastro stem cell therapy, in a deal worth 520 million euros ($626 million). The decision follows ...
Prompted by previous evidence, we designed the nationwide ‘STEM cell mobilization in Acute Myocardial Infarction OUTCOME’ (STEM-AMI OUTCOME) trial to verify whether early therapy with G-CSF in ...
The gene therapy improved myocardial outcomes even when cardiac ... CMYA5 gene therapy on human cardiomyocytes derived from stem cells. These cardiomyocytes typically don't make dyads, perhaps ...
Recent trends in the incidence, treatment, and outcomes of patients ... exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction.
RCCS San Raffaele Scientific Institute in Milan researchers have discovered that hematopoietic stem cells (HSCs) adapt their lineage commitment during gene therapy based on the underlying genetic ...
Stem cell therapy represents a groundbreaking approach in the field of regenerative medicine. It leverages the body’s stem cells to repair knee cartilage, reduce inflammation, and stimulate ...
Stem cells grown in microgravity aboard the International Space Station (ISS) have unique qualities that could one day help accelerate new biotherapies and heal complex disease, researchers say. The ...